Oisín N. Kavanagh

Oisín N. Kavanagh


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Drug Discovery Today
Verified
Journal Article
Closed access
OKOisin Kavanagh
Oisin Kavanagh
DCDenise M. Croker
Denise M. Croker
GWGavin Walker
Gavin Walker
MZMike Zaworotko
Mike Zaworotko

1 July 2016 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
CMConor McEwan
Conor McEwan
HNHeather Nesbitt
Heather Nesbitt
DNDean Nicholas
Dean Nicholas
OKOisin Kavanagh
Oisin Kavanagh
KMKevin McKenna
Kevin McKenna
JCJohn F Callan
John F Callan

1 August 2018 in Journal of Controlled Release
Verified
Journal Article
Closed access
OKOisin Kavanagh
Oisin Kavanagh
AAAhmad B. Albadarin
Ahmad B. Albadarin
DCDenise M. Croker
Denise M. Croker
Anne Marie HealyAnne Marie Healy
Anne Marie Healy
GWGavin Walker
Gavin Walker

29 June 2023 in Crystal Growth & Design
Verified
Journal Article
Open access
MHMolly M. Haskins
Molly M. Haskins
OKOisin Kavanagh
Oisin Kavanagh
RSRana Sanii
Rana Sanii
SKSanaz Khorasani
Sanaz Khorasani
JCJia-Mei Chen
Jia-Mei Chen
MZMike Zaworotko
Mike Zaworotko
Quercetin (QUE) is a widely studied nutraceutical with a number of potential therapeutic properties. Although QUE is abundant in the plant kingdom, its poor solubility (≤20 μg/mL) and poor oral bioavailability have impeded its potential utility and clinical development. In this context, cocrystallization has emerged as a useful method for improving the physicochemical properties of biologically active molecules. We herein report a novel cocrystal of the nutraceutical quercetin (QUE) with the coformer pentoxifylline (PTF) and a solvate of a previously reported structure between QUE and betaine (BET). We also report the outcomes of in vitro and in vivo studies of QUE release and absorption from a panel of QUE cocrystals: betaine (BET), theophylline (THP), l-proline (PRO), and novel QUEPTF. All cocrystals were found to exhibit an improvement in the dissolution rate of QUE. Further, the QUE plasma levels in Sprague-Dawley rats showed a 64-, 27-, 10- and 7-fold increase in oral bioavailability for QUEBET·MeOH, QUEPTF, QUEPRO, and QUETHP, respectively, compared to QUE anhydrate. We rationalize our in vivo and in vitro findings as the result of dissolution-supersaturation-precipitation behavior.

7 August 2019 in Crystal Growth & Design
Verified
Journal Article
Closed access
OKOisin Kavanagh
Oisin Kavanagh
GWGavin Walker
Gavin Walker
MLMatteo Lusi
Matteo Lusi

1 October 2020 in Medical Hypotheses
Verified
Journal Article
Closed access
OKOisin Kavanagh
Oisin Kavanagh
AHAnne Marie Healy
Anne Marie Healy
FDFrancis Dayton
Francis Dayton
SRShane Robinson
Shane Robinson
NONiall J. O’Reilly
Niall J. O’Reilly
JFJohn P. Farragher
John P. Farragher